FATN vs RARE · rev $19.2M vs rev $350.0M
FatPipe, Inc. Common Stock (FATN) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
FatPipe, Inc. Common Stock (FATN) is a software - infrastructure company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported FATN revenue for 2026-03-31 was $19.2M. Net income was $5.0M. Revenue was up 17.9% from 2025-03-31 to 2026-03-31. FATN currently screens at market cap $0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
FATN currently screens at market cap $0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the FATN and RARE stock pages for the full models.
Not investment advice.